Parameter Predicting Postoperative Atrial Fibrillation in Coronary Artery Bypass Grafting Patients:

İlhan Koyuncu1, Emin Koyun2

  • 1Department of Cardiology, Bakircay University, Cigli Training and Research Hospital, İzmir - Turquia.

Insights

The Triglyceride-Cholesterol-Body weight Index (TCBI) can predict postoperative atrial fibrillation (POAF) after coronary artery bypass grafting (CABG). Low preoperative TCBI indicates a higher risk of developing POAF.

Area of Science:

  • Cardiology
  • Surgical Outcomes
  • Biomarkers

Background:

  • Postoperative atrial fibrillation (POAF) is a frequent complication following cardiac surgery, especially coronary artery bypass grafting (CABG).
  • POAF significantly increases patient morbidity and mortality despite surgical advancements.

Purpose of the Study:

  • To evaluate the Triglyceride-Cholesterol-Body weight Index (TCBI) as a predictive marker for POAF.
  • To assess the influence of nutritional status, indicated by TCBI, on outcomes after CABG.

Main Methods:

  • A retrospective analysis of 321 patients undergoing CABG between January 2010 and January 2024.
  • Preoperative TCBI levels were calculated and compared between patients who developed POAF and those who did not.
  • Statistical methods included Cox regression and ROC analysis to determine TCBI's predictive accuracy for POAF.

Main Results:

  • Patients who developed POAF exhibited significantly lower TCBI levels compared to those without POAF (p<0.001).
  • TCBI was identified as an independent predictor of POAF (OR: 0.998, p<0.001), with a cut-off of 1932.4 offering 75% sensitivity and 78% specificity.
  • Higher age, hypertension, CRP, and WBC were also associated with increased POAF risk.

Conclusions:

  • The TCBI serves as a reliable preoperative indicator for predicting POAF in CABG patients.
  • Identifying patients with low TCBI preoperatively allows for targeted interventions to reduce complications.
  • Optimizing preoperative nutritional status may be a strategy to mitigate POAF risk.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...